Form 4 · Filed Jun 10, 2026, 10:04 AM UTC
INDV/Indivior Pharmaceuticals, Inc.
Preblick Ryan — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | S | sell | 36,000 | $38 | $1,357,200 | 284,751 |
Source: SEC EDGAR raw filing ↗ · Accession 0002014866-26-000011